These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20093830)

  • 1. Novel insights into the pathobiology of the vascular access - do they translate into improved care?
    Diskin CJ
    Blood Purif; 2010; 29(2):216-29. PubMed ID: 20093830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.
    Roy-Chaudhury P; Sukhatme VP; Cheung AK
    J Am Soc Nephrol; 2006 Apr; 17(4):1112-27. PubMed ID: 16565259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between vascular access failure and the use of specific drugs: the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Saran R; Dykstra DM; Wolfe RA; Gillespie B; Held PJ; Young EW;
    Am J Kidney Dis; 2002 Dec; 40(6):1255-63. PubMed ID: 12460045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of new concepts in vascular physiology and pharmacology to improve hemodialysis access outcomes.
    Diskin CJ
    Minerva Urol Nefrol; 2010 Dec; 62(4):387-410. PubMed ID: 20944540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular access in hemodialysis: issues, management, and emerging concepts.
    Roy-Chaudhury P; Kelly BS; Melhem M; Zhang J; Li J; Desai P; Munda R; Heffelfinger SC
    Cardiol Clin; 2005 Aug; 23(3):249-73. PubMed ID: 16084276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies.
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    Nat Clin Pract Nephrol; 2008 Nov; 4(11):628-38. PubMed ID: 18813234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular access for hemodialysis: an indepth review.
    Patel NH; Revanur VK; Khanna A; Hodges C; Jindal RM
    J Nephrol; 2001; 14(3):146-56. PubMed ID: 11439737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular access-related thrombotic complications: research hypotheses and therapeutic strategies.
    Bruno S; Remuzzi G
    J Nephrol; 2006; 19(3):280-5. PubMed ID: 16874686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial progenitor cells, neointimal hyperplasia, and hemodialysis vascular access dysfunction: novel therapies for a recalcitrant clinical problem.
    Roy-Chaudhury P
    Circulation; 2005 Jul; 112(1):3-5. PubMed ID: 15998692
    [No Abstract]   [Full Text] [Related]  

  • 10. Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs.
    Luo Z; Akita GY; Date T; Treleaven C; Vincent KA; Woodcock D; Cheng SH; Gregory RJ; Jiang C
    Circulation; 2005 Apr; 111(13):1679-84. PubMed ID: 15781730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.
    Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A
    Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
    Polkinghorne K;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
    [No Abstract]   [Full Text] [Related]  

  • 13. [Distal vascular access for chronic hemodialysis in patients over 65 years of age. Surgical results].
    Cante P; Bottet P; Ryckelynck JP; Le Roch B; Levaltier B; Lobbedez T; Bensadoun H
    Prog Urol; 1998 Feb; 8(1):83-8. PubMed ID: 9533157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemodialysis access--a vascular surgical problem].
    Hedin U
    Lakartidningen; 2011 Feb 23-Mar 1; 108(8):406-10. PubMed ID: 21485475
    [No Abstract]   [Full Text] [Related]  

  • 15. Current management of vascular access.
    Allon M
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):786-800. PubMed ID: 17699495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of complications of hemodialysis vascular accesses].
    Chanis G
    Rev Med Panama; 2000; 25():11-8. PubMed ID: 15881742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long life to the permanent vascular access for hemodialysis].
    Gómez Campderá F; Polo JR
    Nefrologia; 2004; 24(2):97-102. PubMed ID: 15219084
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
    Lee YK; Koo JR; Kim JK; Park II; Joo MH; Yoon JW; Noh JW; Vaziri ND
    Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical protocol. A phase IIb, randomized, multicenter, double-blind study of the efficacy and safety of Trinam (EG004) in stenosis prevention at the graft-vein anastomosis site in dialysis patients.
    Fuster V; Charlton P; Boyd A
    Hum Gene Ther; 2001 Nov; 12(16):2025-7. PubMed ID: 11727735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective monitoring of vascular access in hemodialysis by means of a multidisciplinary team].
    Gruss E; Portolés J; Jiménez P; Hernández T; Rueda JA; del Cerro J; Lasala M; Tato A; Gago MC; Martínez S; Velayos P
    Nefrologia; 2006; 26(6):703-10. PubMed ID: 17227248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.